Literature DB >> 2508547

Antibiotic treatment and intestinal colonization by Pseudomonas aeruginosa in cancer patients.

A Andremont1, B Marang, C Tancrède, D Baume, C Hill.   

Abstract

To determine whether antibiotic treatment increases the risk of colonization by Pseudomonas aeruginosa, we performed a case-control study comparing antibiotic exposure in cancer patients colonized by P. aeruginosa and in noncolonized controls. Of 88 patients, 76 had been exposed to at least one antibiotic, but colonization was not statistically associated with exposure to any specific antibiotic treatment, administered orally or parenterally, alone or in combination.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2508547      PMCID: PMC172666          DOI: 10.1128/AAC.33.8.1400

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  12 in total

1.  Antibiotic resistance from food.

Authors:  D E Corpet
Journal:  N Engl J Med       Date:  1988-05-05       Impact factor: 91.245

2.  Epidemiology of intestinal colonization by members of the family Enterobacteriaceae resistant to cefotaxime in a hematology-oncology unit.

Authors:  M H Prevot; A Andremont; H Sancho-Garnier; C Tancrede
Journal:  Antimicrob Agents Chemother       Date:  1986-12       Impact factor: 5.191

3.  Epidemiology of intestinal colonization by members of the family Enterobacteriaceae highly resistant to erythromycin in a hematology-oncology unit.

Authors:  A Andremont; H Sancho-Garnier; C Tancrede
Journal:  Antimicrob Agents Chemother       Date:  1986-06       Impact factor: 5.191

4.  Occasional notes. Please don't eat the salads.

Authors:  J S Remington; S C Schimpff
Journal:  N Engl J Med       Date:  1981-02-12       Impact factor: 91.245

5.  The fate of ingested Pseudomonas aeruginosa in normal persons.

Authors:  A C Buck; E M Cooke
Journal:  J Med Microbiol       Date:  1969-11-04       Impact factor: 2.472

6.  Effect of erythromycin on microbial antagonisms: a study in gnotobiotic mice associated with a human fecal flora.

Authors:  A Andremont; P Raibaud; C Tancrède
Journal:  J Infect Dis       Date:  1983-09       Impact factor: 5.226

7.  Bacterial translocation and gram-negative bacteremia in patients with hematological malignancies.

Authors:  C H Tancrède; A O Andremont
Journal:  J Infect Dis       Date:  1985-07       Impact factor: 5.226

8.  Effect of broad-spectrum parenteral antibiotics on "colonization resistance" of intestinal microflora of humans.

Authors:  M Barza; M Giuliano; N V Jacobus; S L Gorbach
Journal:  Antimicrob Agents Chemother       Date:  1987-05       Impact factor: 5.191

9.  Protective role of intestinal flora against infection with Pseudomonas aeruginosa in mice: influence of antibiotics on colonization resistance.

Authors:  D J Hentges; A J Stein; S W Casey; J U Que
Journal:  Infect Immun       Date:  1985-01       Impact factor: 3.441

10.  Antibiotic-resistant bacteria in surveillance stool cultures of patients with prolonged neutropenia.

Authors:  J R Wingard; J Dick; P Charache; R Saral
Journal:  Antimicrob Agents Chemother       Date:  1986-09       Impact factor: 5.191

View more
  9 in total

Review 1.  Host stress and virulence expression in intestinal pathogens: development of therapeutic strategies using mice and C. elegans.

Authors:  Olga Zaborina; Alexander Zaborin; Kathleen Romanowski; Trissa Babrowski; John Alverdy
Journal:  Curr Pharm Des       Date:  2011       Impact factor: 3.116

2.  Clearance of Pseudomonas aeruginosa from the murine gastrointestinal tract is effectively mediated by O-antigen-specific circulating antibodies.

Authors:  G B Pier; G Meluleni; J B Goldberg
Journal:  Infect Immun       Date:  1995-08       Impact factor: 3.441

3.  A murine model of chronic mucosal colonization by Pseudomonas aeruginosa.

Authors:  G B Pier; G Meluleni; E Neuger
Journal:  Infect Immun       Date:  1992-11       Impact factor: 3.441

4.  Role of bacterial association with Kupffer cells in occurrence of endogenous systemic bacteremia.

Authors:  Y Hirakata; K Tomono; K Tateda; T Matsumoto; N Furuya; K Shimoguchi; M Kaku; K Yamaguchi
Journal:  Infect Immun       Date:  1991-01       Impact factor: 3.441

5.  Identification of multi-drug resistant Pseudomonas aeruginosa clinical isolates that are highly disruptive to the intestinal epithelial barrier.

Authors:  Olga Zaborina; Jonathan E Kohler; Yingmin Wang; Cindy Bethel; Olga Shevchenko; Licheng Wu; Jerrold R Turner; John C Alverdy
Journal:  Ann Clin Microbiol Antimicrob       Date:  2006-06-08       Impact factor: 3.944

6.  Antimicrobial combination treatment including ciprofloxacin decreased the mortality rate of Pseudomonas aeruginosa bacteraemia: a retrospective cohort study.

Authors:  M Paulsson; A Granrot; J Ahl; J Tham; F Resman; K Riesbeck; F Månsson
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-01-21       Impact factor: 3.267

Review 7.  Pseudomonas aeruginosa Infections in Cancer Patients.

Authors:  Paulina Paprocka; Bonita Durnaś; Angelika Mańkowska; Grzegorz Król; Tomasz Wollny; Robert Bucki
Journal:  Pathogens       Date:  2022-06-12

8.  Bacterial Ghosts of Pseudomonas aeruginosa as a Promising Candidate Vaccine and Its Application in Diabetic Rats.

Authors:  Salah A Sheweita; Amro A Amara; Heba Gamal; Amany A Ghazy; Ahmed Hussein; Mohammed Bahey-El-Din
Journal:  Vaccines (Basel)       Date:  2022-06-07

Review 9.  Pathogenesis of intestinal Pseudomonas aeruginosa infection in patients with cancer.

Authors:  Panayiota Markou; Yiorgos Apidianakis
Journal:  Front Cell Infect Microbiol       Date:  2014-01-07       Impact factor: 5.293

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.